Morrison Scott W
SEC-identified person · CIK 1662426 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Tarsus Pharmaceuticals, Inc. TARS | Director | filed 2022 - 2026 |
| Zai Lab Ltd ZLAB | Director | filed 2021 - 2026 |
| Ideaya Biosciences, Inc. IDYA | Director | filed 2019 - 2026 |
| Vera Therapeutics, Inc. VERA | Director | filed 2021 - 2026 |
| Corvus Pharmaceuticals, Inc. CRVS | Director | filed 2016 - 2025 |
| Global Blood Therapeutics, Inc. GBT | Director | filed 2016 - 2022 |
| Audentes Therapeutics, Inc. BOLD | Director | filed 2016 - 2020 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.